Sponsor pipeline

SparingVision clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-10-02	NCT07854899 Natural History Study of Advanced RCD		Recruiting

Phase 1/2

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 1/2
NCT07807111	Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy…	Retinitis Pigmentosa (RP)	Recruiting	2026-09-08
NCT05748873	Promising ROd-cone DYstrophy Gene therapY	Retinitis Pigmentosa	Active, Not Recruiting	2026-05-15
Not applicable
NCT07854899	Natural History Study of Advanced RCD	Rod Cone Dystrophy	Recruiting	2026-10-08
NCT04285398	Prospective Natural History Study of Retinitis Pigmentosa	Retinitis Pigmentosa	Active, Not Recruiting	2025-05-22

Get alerts when SparingVision's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.